Secondhand Smoke Exposure and Metabolic Dysfunction- associated Steatotic Liver Disease in US Adolescents

被引：0
|
作者：
Kim, Donghee [1 ]
Perumpail, Brandon j. [2 ]
Danpanichkul, Pojsakorn [3 ]
Wijarnpreecha, Karn [4 ,5 ]
Ahmed, Aijaz [1 ]
机构：
[1] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, 300 Pasteur Dr, Stanford, CA 94304 USA
[2] St Christophers Hosp Children, Dept Pediat, Philadelphia, PA USA
[3] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX USA
[4] Univ Arizona, Coll Med, Dept Med, Div Gastroenterol & Hepatol, Phoenix, AZ USA
[5] Banner Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Med Ctr, Phoenix, AZ USA
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2025年 / 23卷 / 04期
关键词：
NONALCOHOLIC FATTY LIVER; PASSIVE SMOKING;
D O I：
10.1016/j.cgh.2024.08.049
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Acomplementto epigenetics in metabolic dysfunction- associated steatotic liver disease: Editorial on "DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction- associated steatotic liver disease"
    Distefano, Johanna K.
    Gerhard, Glenn S.
    CLINICAL AND MOLECULAR HEPATOLOGY, 2025, 31 (01)
  • [2] Emerging role of natural lipophagy modulators in metabolic dysfunction- associated steatotic liver disease
    El-Ashmawy, Nahla E.
    Khedr, Eman G.
    Al-Ashmawy, Ghada M.
    Kamel, Asmaa A.
    NUTRITION, 2024, 126
  • [3] THE LIPIDOMIC PROFILE DISCRIMINATES BETWEEN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND COMBINED METABOLIC DYSFUNCTION- AND ALCOHOL-RELATED STEATOTIC LIVER DISEASE
    Schneider, Carolin Victoria
    Loomba, Rohit
    Huang, Helen
    Raptis, Anastasia
    Creasy, Kate Townsend
    Clusmann, Jan
    Van Haag, Felix
    Luedde, Tom
    Francque, Sven
    Schneider, Kai Markus
    HEPATOLOGY, 2024, 80 : S453 - S454
  • [4] PHOCAEICOLA COPROCOLA ALLEVIATES METABOLIC DYSFUNCTION- ASSOCIATED STEATOTIC LIVER DISEASE BY MODULATING LIPOGENESIS
    Park, JeongHa
    Song, Seol Hee
    Kim, Jeong Su
    Kown, Young Seok
    Kim, Dong Joon
    HEPATOLOGY, 2024, 80 : S61 - S62
  • [5] Nonalcoholic Fatty Liver Disease Gets Renamed as Metabolic Dysfunction- Associated Steatotic Liver Disease: Progress But With Challenges
    Allen, Alina M.
    Pose, Elisa
    Reddy, K. Rajender
    Russo, Mark W.
    Kamath, Patrick S.
    GASTROENTEROLOGY, 2024, 166 (02) : 229 - 234
  • [6] Sex-specific associations of metabolic dysfunction- associated steatotic liver disease with cardiovascular outcomes
    Miao, Meng-Yuan
    Lyu, Jie-Qiong
    Jiang, Wei
    Liu, Zhong-Yue
    Chen, Guo-Chong
    CLINICAL AND MOLECULAR HEPATOLOGY, 2025, 31 (01)
  • [7] Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease and Cardiometabolic Risk Factor in US Adolescents
    Zheng, Xiaoyan
    Zhao, Dongying
    Wang, Liwei
    Wang, Yiwen
    Chen, Yan
    Zhang, Yongjun
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [8] Glycemic Dysregulation Detected by Continuous Glucose Monitoring in Children With Metabolic Dysfunction- Associated Steatotic Liver Disease
    Huneault, Helaina
    Tovar, Ana Ramirez
    Sanchez-Torres, Cristian
    Yaranga, Claudia
    DeSantos, Karla
    He, Zhulin
    Aguayo, Liliana
    Welsh, Jean A.
    Vos, Miriam B.
    CIRCULATION, 2024, 149
  • [9] Novel Multimodal Database for Metabolic Dysfunction- Associated Steatotic Liver Disease-Linking Genes to Outcomes
    Naimimohasses, Sara
    Bhat, Mamatha
    GASTROENTEROLOGY, 2024, 167 (02) : 410 - 411
  • [10] ASSOCIATION OF BIOMARKERS WITH HEPATIC COLLAGEN QUANTIFICATION IN PATIENTS WITH METABOLIC DYSFUNCTION- ASSOCIATED STEATOTIC LIVER DISEASE ( MASLD)
    Tan, Daisong
    Koenig, Aaron
    Felix, Sean
    Estep, Michael
    Monge, Fanny
    Lam, Brian
    Racila, Andrei
    Stepanova, Maria
    Goodman, Zachary
    Younossi, Zobair
    HEPATOLOGY, 2024, 80 : S1535 - S1536
12345